Healthcare provider profile · identity verified

Ildefonzo Flores, M.D.

Internal Medicine · LAREDO, TX · NPI 1205867595

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	380	110
Glimepiride	Glimepiride	244	77
Azithromycin	Azithromycin	229	143
Gabapentin	Gabapentin	220	81
Alprazolam	Alprazolam	207	43
Atorvastatin Calcium	Atorvastatin Calcium	198	65
Metoprolol Succinate	Metoprolol Succinate	188	60
Losartan Potassium	Losartan Potassium	170	52
Metformin Hcl	Metformin Hcl	159	50
Dexamethasone	Dexamethasone	150	113
Amlodipine Besylate	Amlodipine Besylate	143	46
Rosuvastatin Calcium	Rosuvastatin Calcium	142	50
Diclofenac Sodium	Diclofenac Sodium	139	69
Simvastatin	Simvastatin	131	38
Pantoprazole Sodium	Pantoprazole Sodium	118	34
Duloxetine Hcl	Duloxetine Hcl	110	39
Clopidogrel	Clopidogrel Bisulfate	104	29
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	103	58
Montelukast Sodium	Montelukast Sodium	103	34
Pioglitazone Hcl	Pioglitazone Hcl	96	35
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	91	30
Enalapril Maleate	Enalapril Maleate	86	28
Hydralazine Hcl	Hydralazine Hcl	83	25
Gemfibrozil	Gemfibrozil	82	24
Eszopiclone	Eszopiclone	80	28
Omeprazole	Omeprazole	79	32
Donepezil Hcl	Donepezil Hcl	78	31
Cephalexin	Cephalexin	76	54
Furosemide	Furosemide	76	39
Zolpidem Tartrate	Zolpidem Tartrate	74	16
Sertraline Hcl	Sertraline Hcl	72	23
Carvedilol	Carvedilol	71	27
Meloxicam	Meloxicam	70	33
Tamsulosin Hcl	Tamsulosin Hcl	69	25
Tramadol Hcl	Tramadol Hcl	68	21
Ibuprofen	Ibuprofen	66	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	63	49
Metoclopramide Hcl	Metoclopramide Hcl	63	44
Fenofibrate	Fenofibrate	62	21
Metronidazole	Metronidazole	60	45
Methylprednisolone	Methylprednisolone	59	46
Clonazepam	Clonazepam	58	13
Tizanidine Hcl	Tizanidine Hcl	57	26
Meclizine Hcl	Meclizine Hcl	56	24
Alendronate Sodium	Alendronate Sodium	55	18
Escitalopram Oxalate	Escitalopram Oxalate	51	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	51	26
Naproxen	Naproxen	51	32
Trazodone Hcl	Trazodone Hcl	50	18
Potassium Chloride	Potassium Chloride	49	21
Pravastatin Sodium	Pravastatin Sodium	48	14
Azelastine Hcl	Azelastine Hcl	47	27
Fenofibrate	Fenofibrate Nanocrystallized	47	19
Metoprolol Tartrate	Metoprolol Tartrate	47	12
Finasteride	Finasteride	46	16
Levofloxacin	Levofloxacin	46	39
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	46	24
Acetaminophen-Codeine	Acetaminophen With Codeine	44	16
Jardiance	Empagliflozin	42	suppressed
Famotidine	Famotidine	41	17
Lansoprazole	Lansoprazole	41	17
Triamcinolone Acetonide	Triamcinolone Acetonide	41	21
Oxybutynin Chloride Er	Oxybutynin Chloride	40	17
Lisinopril	Lisinopril	39	12
Baclofen	Baclofen	38	23
Nabumetone	Nabumetone	38	21
Nifedipine Er	Nifedipine	38	13
Pregabalin	Pregabalin	38	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	37	12
Celecoxib	Celecoxib	36	11
Ezetimibe	Ezetimibe	35	13
Hydrochlorothiazide	Hydrochlorothiazide	35	12
Lorazepam	Lorazepam	35	suppressed
Betaxolol Hcl	Betaxolol Hcl	33	suppressed
Topiramate	Topiramate	32	suppressed
Labetalol Hcl	Labetalol Hcl	31	suppressed
Acarbose	Acarbose	30	13
Buspirone Hcl	Buspirone Hcl	30	12
Hydroxyzine Hcl	Hydroxyzine Hcl	30	12
Lovastatin	Lovastatin	30	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	29	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Atenolol	Atenolol	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	17
Eliquis	Apixaban	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Megestrol Acetate	Megestrol Acetate	22	13
Verapamil Er	Verapamil Hcl	22	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Mupirocin	Mupirocin	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Ursodiol	Ursodiol	20	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Valsartan	Valsartan	19	suppressed
Cilostazol	Cilostazol	18	suppressed
Primidone	Primidone	18	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Colchicine	Colchicine	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Desmopressin Acetate	Desmopressin Acetate	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Terconazole	Terconazole	16	suppressed
Metolazone	Metolazone	15	suppressed
Ramipril	Ramipril	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Ozempic	Semaglutide	14	suppressed
Allopurinol	Allopurinol	13	suppressed
Cefdinir	Cefdinir	13	11
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Prednisone	Prednisone	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error